Octapharma AB Octapharma GmbH Octapharma Pharmazeutika Produktionsges.m.b.H.

Cutaquig is used in adults and children to supplement antibody (immunoglobulin) deficiency. It is intended for individuals with primary immunodeficiency (born with a reduced ability to produce antibodies) and individuals with acquired immunodeficiency who experience severe or recurrent infections.

Dosage form: solution for injection

ATC: J06BA01

The medicine is used for the treatment of bleeding episodes and for prophylaxis during surgical procedures in individuals with congenital fibrinogen deficiency. It is also used to supplement fibrinogen deficiency in patients with severe, uncontrolled bleeding acquired during surgery.

Dosage form: powder and solvent for solution for injection and infusion

ATC: B02BB01